Daniel A. Fernandez Felix
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daniel A. Fernandez Felix has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Carlos E. Arias Morales
Medicine, St. Barnabas Hospital (SBH) Health System, Bronx, USA
2 shared publications - Gloriana Madrigal Loria
Medicine, St. Barnabas Hospital (SBH) Health System, Bronx, USA
2 shared publications - Sapna Sharma
Internal Medicine, Mahatma Gandhi Mission Institute of Health Sciences, Navi Mumbai, USA
2 shared publications - Mahmoud Ali
Medicine, SBH (St. Barnabas Hospital) Health System, New York City, USA
1 shared publication - Shorabh Sharma
Medicine, St. Barnabas Hospital (SBH) Health System, Bronx, USA
1 shared publication
Latest Publications
- Open Access
- 10 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e25818
A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
Empagliflozin-induced euglycemic diabetic ketoacidosis is a life-threatening metabolic complication of diabetes mellitus characterized by metabolic acidosis, ketonemia, and relatively normal serum glucose levels. We present a rare case of empagliflozin-induced diabetic ketoacidosis obscured by alkalosis. This case report aims to create awareness among clinicians about this entity and consider this diagnosis in their differential, especially in patients taking sodium-glucose co-transporter (SGLT-2) inhibitors who present to the hospital with unspecific symptoms that may not suggest DKA.
- 10 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e25818
Open AccessA Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
Empagliflozin-induced euglycemic diabetic ketoacidosis is a life-threatening metabolic complication of diabetes mellitus characterized by metabolic acidosis, ketonemia, and relatively normal serum glucose levels. We present a rare case of empagliflozin-induced diabetic ketoacidosis obscured by alkalosis. This case report aims to create awareness among clinicians about this entity and consider this diagnosis in their differential, especially in patients taking sodium-glucose co-transporter (SGLT-2) inhibitors who present to the hospital with unspecific symptoms that may not suggest DKA.
- Open Access
- 30 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e25498
Emphysematous Pyelonephritis Complicated With Hyperglycemic Hyperosmolar State and Sepsis: A Case Report and Literature Review
Emphysematous pyelonephritis (EPN) is an acute life-threatening necrotizing infection of the renal parenchyma and perirenal tissues. There are multiple treatment strategies for EPN depending on the initial classification; over the last three decades, the treatment approach has favored kidney sparing strategies and the use of nephrectomy only as salvage therapy. We report a case involving a patient with unilateral emphysematous pyelonephritis complicated with hyperglycemic hyperosmolar state (HHS), sepsis, and multiple risk factors associated with poor prognosis who was successfully treated with conservative management sparing nephrectomy. This case report aims to create awareness among clinicians that even in the presence of multiple risk factors for poor prognosis, conservative management should be considered before nephrectomy.
- 30 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e25498
Open AccessEmphysematous Pyelonephritis Complicated With Hyperglycemic Hyperosmolar State and Sepsis: A Case Report and Literature Review
Emphysematous pyelonephritis (EPN) is an acute life-threatening necrotizing infection of the renal parenchyma and perirenal tissues. There are multiple treatment strategies for EPN depending on the initial classification; over the last three decades, the treatment approach has favored kidney sparing strategies and the use of nephrectomy only as salvage therapy. We report a case involving a patient with unilateral emphysematous pyelonephritis complicated with hyperglycemic hyperosmolar state (HHS), sepsis, and multiple risk factors associated with poor prognosis who was successfully treated with conservative management sparing nephrectomy. This case report aims to create awareness among clinicians that even in the presence of multiple risk factors for poor prognosis, conservative management should be considered before nephrectomy.